Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting enzymes involved in inflammatory and oncogenic signaling pathways. Its structure supports binding to ATP sites in kinases, making it valuable in designing drugs for cancer and autoimmune diseases. Also investigated for improving metabolic stability and bioavailability in oral formulations due to its tetrazole and quinolinone moieties.